ReviewPharmacoEconomics2013
Pazopanib for the first-line treatment of patients with advanced and/or metastatic renal cell carcinoma : a NICE single technology appraisal.
Mary Kilonzo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled itcites it